MedPath

Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillatio

Completed
Conditions
atrial fibrillation
palpitations
10007521
Registration Number
NL-OMON53352
Lead Sponsor
niversity of Utah health Sciences Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

- Patients with persistent AF undergoing first AF ablation as per recent HRS consensus document. Persistent AF is defined by 7 days or more in AF as evidenced by either 1) rhythm strip or 2) written documentation.
- Must have some proportion of atrial fibrosis (not limited to advanced stage fibrosis).
- Able to understand and willing to sign the Informed Consent Form.
- Age * 18 years.

Exclusion Criteria

- Contraindication for DE-MRI with a full dose of Gadolinium-based contrast agent.
- Previous left atrial ablation or surgical procedure.
- Women currently pregnant.
- Mental or physical inability to take part in the study.
- Uncontrolled hypertension.
- Inability to be placed in MRI due to body mass.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To examine the efficacy of targeting atrial fibrosis tissue during an ablation<br /><br>procedure in treating persistent AF.<br /><br><br /><br>The frequencies and proportions of patients experiencing each of three<br /><br>components of the primary AA outcome:<br /><br>atrial fibrillation<br /><br>atrial flutter<br /><br>atrial tachycardia</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Quality of life as measured by the Toronto Score.<br /><br>A composite outcome including AA recurrence and prescription of an<br /><br>anti-arrhythmic medication, stroke, cardiovascular hospitalization, a repeat<br /><br>ablation, AA recurrence following repeat ablation</p><br>
© Copyright 2025. All Rights Reserved by MedPath